Among the top stories in hematology/oncology last week were the FDA issuing draft guidance recommending that men be included in clinical trials of new breast cancer drugs and results of two phase 3 trials that found Keytruda failed to improve clinical outcomes for patients with multiple myeloma. Other highlights […]
Click here to view original web page at www.healio.com